What are monoclonal antibodies?
There is a lot of terminology that comes with a breast cancer diagnosis. Explore how monoclonal antibodies such as Herceptin® work and how to recognise them!
OWise wins top NESTA Healthier Lives Data Fund Prize
Px Healthcare won £60,000 in funding from the Scottish Government to keep developing their products and scale them across Scotland.
NHS Lothian trials groundbreaking OWise cancer patient app
A version of OWise that is integrated into the hospital’s electronic health record system is being trialled at NHS Lothian in Scotland. Read here to see OWise’s feature in The National about this, and how it is benefitting patients and clinicians.
A case study example in the NICE evidence standard framework for digital health technologies.
OWise receives top prize in Scotland’s Cancer Innovation Challenge
OWise was one of the projects selected to win the finals and progress to phase two of the Cancer Innovation Challenge!
NHS Digital approved
OWise is one in five cancer apps listed in the NHS app library.
CE-marked: Class I Medical Device
OWise was CE-marked to comply with the European regulatory standards for safety and usage on the 7th of May, 2014.
OWise breast cancer listed in the Top 25 of all health apps by IQVIA.
OWise breast cancer was listed in the Top 25 of all health apps by IQVIA.
NHS Innovation Accelerator
Anne joined the NHS Innovation Accelerator (NIA) from the Netherlands to develop OWise in 2015. The NIA is facilitating Anne’s … Continue reading “NHS Innovation Accelerator”
First place in the Digital Health Masterclass Challenge 2013
Px HealthCare won first place in the Digital Health Masterclass Challenge held by Janssen Healthcare Innovation and Johnson & Johnson Innovation.